Inbox Robot - Choose newsletter content

Choose content

Enter keywords to create a newsletter

Create account

Enter your registration information

Set preferences

Set up your newsletter name, delivery and time zone preferences

Hint: Enter different keywords to generate new results.

Now you can:

Search the news index.
Browse more than 1 million newsletters by category.
Use preset newsletters:
- Reductase Inhibitors

Reductase Inhibitors Newsletter

Prostatitis and its impact on men's sexual health 27 Apr 2025 02:54 GMT
… as alpha blockers, 5 alpha-reductase inhibitors, NSAIDs, and PDE5-I are …
Prostate-Specific Antigen Monitoring in Men Using 5-Alpha Reductase Inhibitors 25 Feb 2025 12:55 GMT
… prostate enlargement receiving 5-alpha reductase inhibitors: a non-interventional, … methodology, concerns about 5-alpha reductase inhibitors’ effects, biopsy triggers, … patients treated with 5-alpha reductase inhibitors. Source: bmcurol.biomedcentral.com …
The latest in clinical trial results of 5-alpha reductase inhibitors in combination regimens for benign prostatic hyperplasia. 13 Jan 2025 18:07 GMT
… fail conservative treatment. 5-alpha-reductase inhibitors (5-ARIs) is the only …
The Correlation Between Impaired Thyroid Hormone Sensitivity and Diabetic Nephropathy in Euthyroid Patients with Type 2 Diabetes Mellitus 23 Apr 2025 08:00 GMT
… new class of potent aldose reductase inhibitors: design, microwave-assisted synthesis, … from vanillin as potential aldose reductase inhibitors. Mol Divers. 2023;27( … Z. Some sulfonamides as aldose reductase inhibitors: therapeutic approach in diabetes. Arch …
Dutasteride, a 5 alpha reductase inhibitor, could be associated with the exacerbation of inflammation in patients with benign prostatic hyperplasia. 25 Oct 2024 09:04 GMT
α-1 blockers and dutasteride are widely used as agents to treat benign prostatic hyperplasia (BPH); the impact of these drugs on prostatic inflammation is still unclear. Herein, we investigated the impact of α-1 blockers and dutasteride treatment of BPH in …
Testosterone and 5 Alpha Reductase Inhibitor (5ARI) in Benign Prostatic Hyperplasia (BPH): A historical perspective 17 Oct 2024 16:13 GMT
… Bowen, Testosterone and 5 Alpha Reductase Inhibitor (5ARI) in Benign Prostatic Hyperplasia …
5-α Reductase Inhibitors and Prostate Cancer Mortality - Beyond the Abstract 20 Sep 2024 23:53 GMT
5-α reductase inhibitors (5-ARIs) finasteride and dutasteride … cancer using a dual 5α-reductase inhibitor, dutasteride. Expert Rev Anticanc 8 … : Association of Treatment With 5α-Reductase Inhibitors With Time to Diagnosis and …
5-α Reductase Inhibitors and Prostate Cancer Mortality. 29 Aug 2024 11:05 GMT
5-alpha-reductase-inhibitors (5-ARIs) are approved for …
Suicide and Intentional Self-harm Among Older Men Treated With 5-Alpha Reductase Inhibitor or Alpha-blockers for Benign Prostatic Hyperplasia. 07 Jul 2024 22:50 GMT
… in older men using 5-α reductase inhibitors (5-ARIs) and alpha-blockers …
BPH, Bikes and Brotherhood: A New Kind of Men’s Gathering 19 Apr 2025 14:48 GMT
… alpha blockers and 5-alpha reductase inhibitors are available under prescription to …

Satisfied with the content?

Continue to create your account.

Choose content

Create account

Set preferences

EIN MARKETING SOLUTIONS

EIN NEWS SERVICES

ALL NEWS PUBLICATIONS